Key result
Over 4 years, 8.1% developed metabolic syndrome; HMW-adiponectin, but not CRP, was independently associated with this risk, though neither improved prediction over BMI or waist circumference.
Why the study?
Does the measurement of CRP and HMW-adiponectin improve the prediction of metabolic syndrome development compared to BMI or waist circumference in Japanese workers?
Cohort (n=750)
Does the measurement of CRP and HMW-adiponectin improve the prediction of metabolic syndrome development compared to BMI or waist circumference in Japanese workers?
Answers are grounded in this paper and cite their sources.
Traditional markers of adiposity such as BMI and waist circumference remain superior to CRP and HMW-adiponectin for predicting the development of metabolic syndrome.
AIMS: To clarify predictive values of C-reactive protein (CRP) and high-molecular-weight (HMW) adiponectin for development of metabolic syndrome. RESEARCH DESIGN AND METHODS: We conducted a prospective cohort study of Japanese workers who had participated in an annual health checkup in 2007 and 2011. A total of 750 subjects (558 men and 192 women, age 46±8 years) who had not met the criteria of metabolic syndrome and whose CRP and HMW-adiponectin levels had been measured in 2007 were enrolled in this study. Associations between CRP, HMW-adiponectin and development of metabolic syndrome after 4 years were assessed by logistic regression analysis and their predictive values were compared by receiver operating characteristic analysis. RESULTS: Among 750 subjects, 61 (8.1%) developed metabolic syndrome defined by modified National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria and 53 (7.1%) developed metabolic syndrome defined by Japan Society for the Study of Obesity (JASSO) in 2011. Although CRP and HMW-adiponectin were both significantly correlated with development of metabolic syndrome, multivariate logistic regression analysis revealed that HMW-adiponectin but not CRP was associated with metabolic syndrome independently of BMI or waist circumference. Adding these biomarkers to BMI or waist circumference did not improve the predictive value for metabolic syndrome. CONCLUSION: Our findings indicate that the traditional markers of adiposity such as BMI or waist circumference remain superior markers for predicting metabolic syndrome compared to CRP, HMW-adiponectin, or the combination of both among the Japanese population.
No takes yet. Share an insight, caveat, or question.
Saisho et al. (2013) conducted a cohort in Metabolic syndrome (n=750). C-reactive protein (CRP) and high-molecular-weight (HMW) adiponectin vs. Traditional markers of adiposity (BMI or waist circumference) was evaluated on Development of metabolic syndrome. Over 4 years, 8.1% developed metabolic syndrome; HMW-adiponectin, but not CRP, was independently associated with this risk, though neither improved prediction over BMI or waist circumference.
Synapse has enriched 10 related papers. Consider them for comparative context: